ProteoWise, founded by a team of seasoned scientists from Yale University, aims to revolutionize the field of proteomics by providing high-throughput, cost-effective solutions. Their core mission is to bring low-cost, high-throughput proteomics to research labs, simplifying complex processes like the western blot. Their flagship product, Hyperblot, breaks barriers in multiplexed protein analysis, offering a unique combination of high information content and affordability. ProteoWise focuses on driving advancements in biotech by unlocking valuable information in proteomics.
Notable affiliated individuals include scientists from the Strittmatter Lab at Yale University, known for their history of innovation. ProteoWise has achieved significant milestones by introducing Hyperblot, which has the potential to catalyze the next wave in biotech similar to the genomic revolution. The company's impact lies in making advanced proteomic analysis accessible and affordable, thereby accelerating research and discovery in various scientific fields.
